GATA2缺陷患者异基因造血干细胞移植后的长期结局:法国和比利时67例成人与儿童分析
该研究分析了法国和比利时21个中心67例GATA2缺陷患者(中位年龄20.6岁)首次异基因造血干细胞移植的长期结局,1年和5年总生存率分别为83%和72%(中位随访5.6年),并识别出与较差总生存相关的因素。
要点
- 67例GATA2缺陷患者接受异基因造血干细胞移植,中位年龄20.6岁,1年与5年总生存率分别为83%与72%。
- 移植适应症以MDS≤5%原始细胞±免疫缺陷为主(66%),MDS>5%原始细胞占15%,急性髓系白血病占19%。
- 多变量分析中与较差总生存相关的因素包括移植年份、移植前原始细胞过多史和外周血干细胞移植物。
核心结论
- 作者认为,必须通过骨髓监测识别克隆演化,并在出现原始细胞过多之前进行造血干细胞移植。
研究设计与样本
- 回顾性分析法国和比利时21个中心共67例GATA2缺陷患者(中位年龄20.6岁)首次异基因造血干细胞移植的结局。
主要发现
- 100天急性移植物抗宿主病II-IV度和III-IV度的累积发生率分别为42%和13%。
- 2年慢性及广泛性慢性移植物抗宿主病的累积发生率分别为42%和23%。
- 1年和5年复发累积发生率分别为3%和11%。
- 1年和5年总生存率分别为83%和72%(中位随访5.6年)。
- 多变量分析中与较差总生存相关的因素为移植年份、移植前原始细胞过多史和外周血干细胞移植物;移植时年龄、非清髓性预处理和外周血干细胞移植物与增加的非复发死亡率相关。
关键数值与推荐
- 移植适应症:MDS≤5%原始细胞±免疫缺陷占66%,MDS>5%原始细胞占15%,急性髓系白血病占19%。
- 预处理方案:清髓性占85%;抗胸腺细胞球蛋白使用占67%。
临床怎么用
- 作者认为,应通过骨髓监测识别克隆演化,并在出现原始细胞过多之前进行造血干细胞移植。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Modalities and timing of haematopoietic stem cell transplant (HSCT) in patients with GATA2 deficiency are still subject to debate. On June 2022, 67 patients (median age 20.6 years) underwent a first allogeneic HSCT among 21 centres. Indications for HSCT were myelodysplastic syndrome (MDS) ≤5% blasts ± immunodeficiency (66%), MDS >5% blasts (15%), acute myeloid leukaemia (19%). Conditioning regimen was myeloablative in 85% and anti-thymocyte globulins were used in 67%. The cumulative incidence (CInc) of acute graft versus host disease (GvHD) grade II-IV and III-IV at day 100 were 42% and 13%, and CInc of chronic and extensive chronic GvHD at 2 years were 42% and 23%. CInc of relapses was 3% and 11% at 1 and 5 years. Overall survival (OS) at 1 and 5 years was 83% and 72% (median follow-up 5.6 years). The factors associated with worse OS in multivariable analysis were the year of HSCT, a history of excess blasts before transplant and peripheral blood stem cell (PBSC) grafts. Age at HSCT, non-myeloablative conditioning and PBSC grafts were associated with increased non-relapse mortality. In conclusion, bone marrow monitoring to identify clonal evolution and perform HSCT before the appearance of excess blast is mandatory.
引用
- Sicre de Fontbrune F, Chevillon F, Fahd M, et al. Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium. Br J Haematol. 2024. PMID: 39159950. doi:10.1111/bjh.19691
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。